Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia of Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02948283
What this trial is testing

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
AnemiaFatigueFever+10 more
City of Hope Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT00004215
What this trial is testing

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
AnemiaLeukemiaNeutropenia+1 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00091858
What this trial is testing

Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

Who this might be right for
AnemiaCancer
Amgen 1,000
Not applicableEnrolling By InvitationNCT05775224
What this trial is testing

ASH Research Collaborative Data Hub

Who this might be right for
Sickle Cell DiseaseMultiple Myeloma
ASH Research Collaborative 100,000
Very early researchWithdrawnNCT02805868
What this trial is testing

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
MyelofibrosisPolycythemia VeraPrimary Myelofibrosis+1 more
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Not applicableStudy completedNCT01809314
What this trial is testing

An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy

Who this might be right for
Anemia
Hoffmann-La Roche 1,167
Testing effectiveness (Phase 2)Active Not RecruitingNCT06243458
What this trial is testing

RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

Who this might be right for
Low Risk Myelodysplastic Syndromes
GCP-Service International West GmbH 41
Not applicableUnknownNCT04101240
What this trial is testing

Anemia and Red Blood Cells Transfusion in Oncological Surgery

Who this might be right for
AnemiaSurgeryOncology
University Hospital, Brest 300
Early research (Phase 1)Ended earlyNCT00629876
What this trial is testing

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

Who this might be right for
Anemia
Takeda 2
Testing effectiveness (Phase 2)Study completedNCT00027924
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00015925
What this trial is testing

MS-275 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT00144755
What this trial is testing

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell Lymphoma
Lymphoma Study Association 600
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)Study completedNCT00003361
What this trial is testing

Decitabine in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Post-approval studies (Phase 4)UnknownNCT05505006
What this trial is testing

Management of Preoperative Anaemia in Surgical Oncology

Who this might be right for
AnemiaTumor
Azienda Ospedaliera Universitaria Integrata Verona 500
Not applicableStudy completedNCT05960214
What this trial is testing

Cardiac Management of Patients With Thalassemia Minor and Breast Cancer

Who this might be right for
Breast CancerThalassemia MinorHeart Diseases
Istanbul University 26
Not applicableStudy completedNCT04902833
What this trial is testing

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Who this might be right for
Pyruvate Kinase DeficiencyPyruvate Kinase Deficiency AnemiaHereditary Hemolytic Anemia+8 more
Massachusetts General Hospital 18
Not applicableStudy completedNCT00900055
What this trial is testing

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

Who this might be right for
Chronic Myeloproliferative DisordersFanconi AnemiaMultiple Myeloma and Plasma Cell Neoplasm+1 more
OHSU Knight Cancer Institute 213
Next Page